From Yahoo Finance: 2025-05-18 12:05:00

AbbVie’s earnings have dropped almost 70% since its pandemic peak, with a 16% year-to-date stock decline and a high payout ratio of 266%. Medtronic, down 37% from its 2021 highs, has a 47-year dividend increase streak but faces uncertainties due to competition. Pfizer’s 7.6% annual yield and 121.5% payout ratio raise concerns about its dividend sustainability amid revenue declines and heavy research spending.



Read more at Yahoo Finance: They May Have to Make a Cut.